Content about OSI Pharmaceuticals

December 9, 2010
Trial data of investigational lung cancer treatment said to extend survival by more than four months

An investigational treatment for lung cancer made by Boehringer Ingelheim Pharmaceuticals extended patients’ survival by more than four months, according to results of a late-stage clinical trial announced Thursday.

August 26, 2010
Pfizer reports mixed results in late-stage clinical trial

Pfizer reported mixed results this week in a late-stage clinical trial combining two drugs in...

June 7, 2010
Astellas completes acquisition of OSI

Japanese drug maker Astellas Pharma has completed its acquisition of OSI Pharmaceuticals, Astellas said Tuesday....

May 16, 2010
Astellas nabs $4 billion acquisition of OSI

Japanese drug maker Astellas Pharma will acquire U.S.-based OSI Pharmaceuticals for $4 billion, the two...

March 4, 2010
OrbiMed Advisors: Astellas should raise bid for OSI

One of the biggest holders of OSI Pharmaceuticals’ stock has said Japanese drug maker Astellas...

February 28, 2010
Astellas vies for OSI Pharmaceuticals

A Japanese drug maker hopes to buy up a pharmaceutical company based in New York...

January 18, 2010
FDA extends review of lung cancer treatment

The Food and Drug Administration has extended its review period for a lung cancer drug...

© 2013 Drug Store News. All Rights Reserved.